Business Context and Reporting Period
Company: Organigram Global Inc.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Three and six months ended March 31, 2026
Filing Date: May 12, 2026
Principal Executive Offices: Toronto, Ontario, Canada
This filing serves as a cover document submitting interim financial results and management discussion for the first half of fiscal year 2026. The registrant files annual reports under Form 40-F.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data. The following metrics are referenced as being included in the attached exhibits but are not detailed in this text:
- Revenue, Profit, and Margins: Refer to Exhibit 99.2 (Condensed Consolidated Interim Unaudited Financial Statements) and Exhibit 99.1 (MD&A).
- Cash Flow and Liquidity: Refer to Exhibit 99.2.
- Debt: Refer to Exhibit 99.2.
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. Investors must refer to the attached Management's Discussion and Analysis (Exhibit 99.1) and the News Release (Exhibit 99.5) for comparative analysis.
Guidance, Outlook, and Risks
Specific guidance, outlook, management commentary, risks, contingencies, or unusual items are not detailed in the cover document. These disclosures are contained within the attached exhibits, specifically:
- Exhibit 99.1: Management's Discussion and Analysis.
- Exhibit 99.5: News Release announcing results.
Investor Verification Checklist
- Verify the specific revenue and net income figures in Exhibit 99.2 (Financial Statements).
- Review the News Release (Exhibit 99.5) for management's commentary on operational performance.
- Confirm the status of liquidity and debt obligations in the interim financial statements.
- Check for any new risk factors or contingencies disclosed in the MD&A (Exhibit 99.1).
- Validate the certifications provided by the CEO and CFO in Exhibits 99.3 and 99.4.